Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS1 | P23219 | 2/20 | 0.38 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.38 |
| ▸ | MRGPRX4 | Q96LA9 | 1/20 | 0.38 |
| ▸ | MAOB | P27338 | 5/20 | 0.38 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.37 |
| ▸ | ESR1 | P03372 | 1/20 | 0.37 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.37 |
| ▸ | HPGD | P15428 | 1/20 | 0.36 |
| ▸ | PPARG | P37231 | 1/20 | 0.35 |
| ▸ | PPARA | Q07869 | 1/20 | 0.35 |
| ▸ | MAOA | P21397 | 1/20 | 0.35 |
| ▸ | USP2 | O75604 | 1/20 | 0.35 |
| ▸ | ACHE | P22303 | 1/20 | 0.35 |
| ▸ | NR4A2 | P43354 | 1/20 | 0.35 |
| ▸ | DAO | P14920 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10187130 | 0.76 | NFE2L2 (0.33) | PTGS1PTGS2MAOBNFE2L2ESR1 | |
| SCHEMBL20160245 | 0.75 | POLB (0.42) | HPGD | |
| SCHEMBL29852392 | 0.73 | ACHE (0.61) | MRGPRX4MAOBESR1ESR2HPGD | |
| SCHEMBL1021094 | 0.73 | ACHE (0.61) | MRGPRX4MAOBESR1ESR2HPGD | |
| SCHEMBL17138151 | 0.72 | ACHE (0.42) | MAOBACHE | |
| SCHEMBL27483673 | 0.72 | ESR1 (0.43) | MRGPRX4MAOBESR1ESR2HPGD | |
| SCHEMBL5634217 | 0.71 | ESR1 (0.49) | MRGPRX4NFE2L2ESR1ESR2HPGD | |
| SCHEMBL30543222 | 0.71 | ESR1 (0.49) | MRGPRX4NFE2L2ESR1ESR2HPGD | |
| SCHEMBL19193440 | 0.71 | PTGS1 (0.57) | PTGS1PTGS2HPGD | |
| SCHEMBL27772040 | 0.71 | ESR1 (0.45) | MRGPRX4MAOBESR1ESR2HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2017218844-A2 | PHARMACEUTICAL COMPOSITIONS AND THEIR USE FOR TREATMENT OF CANCER AND AUTOIMMUNE DISEASES | Zhejiang DTRM Biopharma Co. Ltd. (CN) | 2017-12-21 | — | — | WO | disclosed |